Could repetitive transcranial magnetic stimulation improve neurocognition in early-onset schizophrenia spectrum disorders?
Paul E
PE
Croarkin
Zafiris J
ZJ
Daskalakis
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008972:Molindone / Q000627:therapeutic use*; D009483:Neuropsychological Tests; D011618:Psychotic Disorders / Q000188:drug therapy*; D018967:Risperidone / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D018967:Risperidone; D008972:Molindone